• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER SELECT; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER SELECT; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 10667
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Obstruction/Occlusion (2422)
Event Date 06/29/2020
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that significant resistance occurred while operating the devices and additional intervention was performed.The patient was diagnosed with deep venous disease (dvd) in the left anterior descending artery (lad) and right coronary artery (rca) and was referred for a double vessel plasty of the lad and rca.Vascular access was obtained via the femoral artery.The 80% stenosed, 2.50x16mm, de novo target lesion was located in the mildly tortuous ramus artery.A 12mm x 3.50 promus premier select was advanced and successfully deployed in the rca.It was then decided that a plasty of the lad would be performed.After crossing a run through wire, predilitation was performed with a non bsc balloon device.A 32 x 3.50mm promus premier select was advanced and deployed at high pressure in the lad due to diffused disease.Soon after deployment of the stent at high pressure in the lad, it was noticed that the ramus became pinched due to a plaque shift and there was no flow in the ramus.It was noted that significant resistance occurred while operating, and the event was likely due to deployment of a stent at high pressure in the lad.A 16 x 2.50 promus premier select stent was advanced immediately to bail out the stenting in the ramus.No further patient complications were reported and the patient was stable, responding well to medication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER SELECT
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10332522
MDR Text Key200614687
Report Number2134265-2020-09908
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 07/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Model Number10667
Device Catalogue Number10667
Device Lot Number0024619367
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/30/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-